Firefly Neuroscience, Inc. (AIFF)
NASDAQ: AIFF · Real-Time Price · USD
2.700
+0.150 (5.88%)
Dec 26, 2024, 4:00 PM EST - Market closed
Company Description
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders.
The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.
It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Firefly Neuroscience, Inc.
| Country | Canada |
| Founded | 2006 |
| Industry | Software - Application |
| Sector | Technology |
| CEO | Jon Olsen |
Contact Details
Address: 150 King St W, Suite 722 Toronto, ON M5H 1J9 Canada | |
| Phone | 888-237-6412 |
| Website | fireflyneuro.com |
Stock Details
| Ticker Symbol | AIFF |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000803578 |
| ISIN Number | US3179701012 |
| Employer ID | 54-1167364 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Jon Olsen | Chief Executive Officer and Director |
| Gil Issachar | Chief Technology Officer |
| David Ian Johnson | Executive Chairman |
| Dr. Jason DuBraski | Vice President of Sales |
| Dr. Samer E. Kaba M.D. | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 23, 2024 | 8-K | Current Report |
| Dec 6, 2024 | ARS | Filing |
| Dec 6, 2024 | DEF 14A | Other definitive proxy statements |
| Dec 4, 2024 | 8-K | Current Report |
| Dec 4, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Dec 3, 2024 | 8-K | Current Report |
| Nov 15, 2024 | 8-K | Current Report |
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Nov 1, 2024 | 8-K | Current Report |
| Sep 27, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |